All batches of seven drugs that used active substances produced in a factory in India where Infarmed sensed failure regarding ‘good manufacturing practice “will be recalled.
At issue are two anti-epileptic drugs and anti-convulsionantes and five anti-inflammatory steroids, with lots for sale in Portugal can not be marketed.
Altogether there are 22 lots Proaxen, eight lots of Zigabal and 18 anti-inflammatory steroids (Aceclofenac).
Related posts: